119 related articles for article (PubMed ID: 6419424)
1. Lack of donor-specific tolerance in mice with established anti-Ia-treated islet allografts.
Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
Transplantation; 1983 Dec; 36(6):691-4. PubMed ID: 6419424
[TBL] [Abstract][Full Text] [Related]
2. Differences in susceptibility to rejection of mouse pancreatic islet allografts disparate for class I or class II major histocompatibility antigens.
Morrow CE; Sutherland DE; Steffes MW; Kaufman D; Najarian JS; Bach FH
J Surg Res; 1983 Apr; 34(4):358-66. PubMed ID: 6403774
[TBL] [Abstract][Full Text] [Related]
3. Rejection of established mouse pancreatic islet allografts by active immunization requires class I (H-2 K, D) antigen disparities.
Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
J Surg Res; 1984 Apr; 36(4):332-40. PubMed ID: 6423894
[TBL] [Abstract][Full Text] [Related]
4. Lack of tolerance to donor-strain skin grafts in mice with established islet allografts.
Gores DF; Sutherland DE; Platt JL; Bach FH
Transplantation; 1987 May; 43(5):749-50. PubMed ID: 2953095
[No Abstract] [Full Text] [Related]
5. The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.
Terasaka R; Lacy PE; Hauptfeld V; Bucy RP; Davie JM
Diabetes; 1986 Jan; 35(1):83-8. PubMed ID: 3079714
[TBL] [Abstract][Full Text] [Related]
6. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
[TBL] [Abstract][Full Text] [Related]
7. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
8. Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.
Gores PF; Sutherland DE; Platt JL; Bach FH
J Immunol; 1986 Sep; 137(5):1482-5. PubMed ID: 3091683
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
Holán V; Hasek M; Chutná J; Holoubková I
Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
[TBL] [Abstract][Full Text] [Related]
11. Effect of anti-Ia antibodies, culture, and cyclosporin on prolongation of canine islet allograft survival.
Alejandro R; Latif Z; Noel J; Shienvold FL; Mintz DH
Diabetes; 1987 Mar; 36(3):269-73. PubMed ID: 3100370
[TBL] [Abstract][Full Text] [Related]
12. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants.
Faustman D; Hauptfeld V; Lacy P; Davie J
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5156-9. PubMed ID: 6795629
[TBL] [Abstract][Full Text] [Related]
14. Immunological characteristics of purified pancreatic islet grafts.
Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
Transplantation; 1986 Oct; 42(4):387-90. PubMed ID: 3094210
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of active tolerance in maintenance of established islet of Langerhans allografts.
Faustman D; Hauptfeld V; Lacy P; Davie J
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4153-5. PubMed ID: 6810361
[TBL] [Abstract][Full Text] [Related]
16. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe M; Yang H; Wolf LA; Gill RG
J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
[TBL] [Abstract][Full Text] [Related]
19. Multiple donor allotransplantation. A new approach to pancreatic islet transplantation.
Gotoh M; Porter J; Kanai T; Monaco AP; Maki T
Transplantation; 1988 Jun; 45(6):1008-12. PubMed ID: 3132760
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
